CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-02 | Malamut Richard Director | Grant or award | +19,108 | 28,012 | ||
| 2025-07-02 | Plesha Scott M. CEO and President | Grant or award | +83,678 | 83,678 | ||
| 2025-07-02 | Greenleaf Peter Director | Grant or award | +25,478 | 25,478 | ||
| 2025-07-02 | Pauls Matthew Director | Grant or award | +25,478 | 25,478 | ||
| 2025-07-02 | Rangarao Sai Chief Commercial Officer | Grant or award | +30,518 | 30,518 | ||
| 2025-07-02 | Baxter Richard B Director | Grant or award | +19,108 | 19,108 | ||
| 2025-07-02 | Francis Knuettel II CFO, Treas & Secty | Grant or award | +33,472 | 33,472 | ||
| 2025-07-02 | Pauls Matthew Director | Option exercise | +8,493 | 8,493 | ||
| 2025-07-02 | Pauls Matthew Director | Option exercise · Restricted Stock Units | −8,493 | 16,985 | ||
| 2025-07-02 | Plesha Scott M. CEO and President | Grant or award · Restricted Stock Units | +83,678 | 83,678 | ||
| 2025-07-02 | Plesha Scott M. CEO and President | Grant or award · Stock Option | +255,000 | 255,000 | ||
| 2025-07-02 | Rangarao Sai Chief Commercial Officer | Grant or award · Restricted Stock Units | +30,518 | 30,518 | ||
| 2025-07-02 | Rangarao Sai Chief Commercial Officer | Grant or award · Stock Option | +93,000 | 93,000 | ||
| 2025-07-02 | Baxter Richard B Director | Grant or award · Restricted Stock Units | +19,108 | 19,108 | ||
| 2025-07-02 | Baxter Richard B Director | Grant or award · Stock Option | +58,230 | 58,230 | ||
| 2025-07-02 | Greenleaf Peter Director | Grant or award · Restricted Stock Units | +25,478 | 25,478 | ||
| 2025-07-02 | Greenleaf Peter Director | Grant or award · Stock Option | +77,640 | 77,640 | ||
| 2025-07-02 | Pauls Matthew Director | Grant or award · Restricted Stock Units | +25,478 | 25,478 | ||
| 2025-07-02 | Pauls Matthew Director | Grant or award · Stock Option | +77,640 | 77,640 | ||
| 2025-07-02 | Francis Knuettel II CFO, Treas & Secty | Grant or award · Restricted Stock Units | +33,472 | 33,472 |
Page 3 of 6 · 115 trades